Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome

Yin, W; Liu, W; Guo, M; Tang, ZY; Toruner, G; Robinson, M; Cheng, J; Hu, SM; Medeiros, LJ; Tang, GL

Tang, GL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.

EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2021; 118 ():

Abstract

MET amplification has been associated with shorter survival in cancer patients and thought to represent one of two major mechanisms for developing res......

Full Text Link